Guangdong Marubi Biotechnology Co Cash Flow Conversion Efficiency
Guangdong Marubi Biotechnology Co cash flow conversion efficiency. Based on the latest financial reports, Guangdong Marubi Biotechnology Co (603983) has a cash flow conversion efficiency ratio of 0.013x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥43.25 Million ≈ $6.33 Million USD) by net assets (CN¥3.39 Billion ≈ $496.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Guangdong Marubi Biotechnology Co stock valuation for the company's overall valuation and market capitalisation.
Cash Flow Conversion Efficiency of Guangdong Marubi Biotechnology Co (2011–2025)
Cash flow conversion efficiency of Guangdong Marubi Biotechnology Co from 2011 to 2025. This chart illustrates how Guangdong Marubi Biotechnology Co's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Guangdong Marubi Biotechnology Co share price for real-time trading data and today's change.
Guangdong Marubi Biotechnology Co Cash Flow Conversion Ratio Explained
Guangdong Marubi Biotechnology Co cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Guangdong Marubi Biotechnology Co Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Guangdong Marubi Biotechnology Co ranked by their cash flow conversion efficiency. Review Guangdong Marubi Biotechnology Co (603983) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
GCS Holdings
TWO:4991
|
0.100x |
|
NP3 Fastigheter AB
ST:NP3
|
0.016x |
|
The South Indian Bank Limited
NSE:SOUTHBANK
|
-0.457x |
|
Tibet Summit Resources Co Ltd
SHG:600338
|
0.052x |
|
Ouster, Inc. Common Stock
NYSE:OUST
|
-0.074x |
|
Indegene Ltd
NSE:INDGN
|
0.065x |
|
Guodian Nanjing Automation Co Ltd
SHG:600268
|
0.290x |
|
Accelevation Holdings Corp. Class A Ordinary Shares
NASDAQ:ACCV
|
-0.420x |
Annual Cash Flow Conversion Efficiency for Guangdong Marubi Biotechnology Co (2011–2025)
The table below shows the annual cash flow conversion efficiency of Guangdong Marubi Biotechnology Co from 2011 to 2025. Also see 603983 total asset value for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥3.39 Billion ≈ $496.67 Million |
CN¥273.88 Million ≈ $40.08 Million |
0.081x | -7.46% |
| 2024-12-31 | CN¥3.45 Billion ≈ $504.33 Million |
CN¥300.53 Million ≈ $43.98 Million |
0.087x | -11.81% |
| 2023-12-31 | CN¥3.42 Billion ≈ $500.24 Million |
CN¥338.02 Million ≈ $49.46 Million |
0.099x | +564.00% |
| 2022-12-31 | CN¥3.25 Billion ≈ $475.96 Million |
CN¥48.44 Million ≈ $7.09 Million |
0.015x | +728.75% |
| 2021-12-31 | CN¥3.16 Billion ≈ $462.18 Million |
CN¥-7.48 Million ≈ $-1.09 Million |
-0.002x | -101.96% |
| 2020-12-31 | CN¥3.00 Billion ≈ $439.09 Million |
CN¥362.35 Million ≈ $53.02 Million |
0.121x | -30.74% |
| 2019-12-31 | CN¥2.67 Billion ≈ $390.69 Million |
CN¥465.53 Million ≈ $68.12 Million |
0.174x | -53.37% |
| 2018-12-31 | CN¥1.38 Billion ≈ $202.21 Million |
CN¥516.69 Million ≈ $75.61 Million |
0.374x | +0.77% |
| 2017-12-31 | CN¥959.96 Million ≈ $140.47 Million |
CN¥356.20 Million ≈ $52.12 Million |
0.371x | +44.03% |
| 2016-12-31 | CN¥828.09 Million ≈ $121.18 Million |
CN¥213.33 Million ≈ $31.22 Million |
0.258x | -32.96% |
| 2015-12-31 | CN¥715.92 Million ≈ $104.76 Million |
CN¥275.11 Million ≈ $40.26 Million |
0.384x | -38.26% |
| 2014-12-31 | CN¥604.48 Million ≈ $88.45 Million |
CN¥376.24 Million ≈ $55.06 Million |
0.622x | -13.40% |
| 2013-12-31 | CN¥453.11 Million ≈ $66.30 Million |
CN¥325.67 Million ≈ $47.66 Million |
0.719x | -25.79% |
| 2012-12-31 | CN¥234.87 Million ≈ $34.37 Million |
CN¥227.49 Million ≈ $33.29 Million |
0.969x | -46.78% |
| 2011-12-31 | CN¥148.02 Million ≈ $21.66 Million |
CN¥269.39 Million ≈ $39.42 Million |
1.820x | -- |
About Guangdong Marubi Biotechnology Co
Guangdong Marubi Biotechnology Co., Ltd. engages in the research and development, design, production, sale, and service of various cosmetics in China. The company offers eye care, skincare, cleansing, and beauty and other products. It sells its products under the Marubi, Lianhuo, Chunji, and Passional Lover brands. The company was founded in 2002 and is based in Guangzhou, China.